Abstract
A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney
BJU International, Vol.122(Supplement 2), pp.30-31
Asia-Pacific Prostate Cancer Conference, 19th (Brisbane, Australia, 22-Aug-2018–25-Aug-2018)
2018
Abstract
No abstract available.
Details
- Title
- A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney
- Authors
- V Nair-Shalliker (Author)A Bang (Author)S Egger (Author)J Rodger (Author)M Clements (Author)R A Gardiner (Author)A Kricker (Author)M Seibel (Author)S K Chambers (Author)Michael G Kimlin (Author) - University of the Sunshine Coast - Faculty of Science, Health, Education and EngineeringB K Armstrong (Author)D P Smith (Author)
- Publication details
- BJU International, Vol.122(Supplement 2), pp.30-31
- Conference details
- Asia-Pacific Prostate Cancer Conference, 19th (Brisbane, Australia, 22-Aug-2018–25-Aug-2018)
- Publisher
- Wiley-Blackwell Publishing Ltd.
- Date published
- 2018
- DOI
- 10.1111/bju.14474
- ISSN
- 1464-4096
- Organisation Unit
- University of the Sunshine Coast, Queensland; School of Health and Sport Sciences - Legacy
- Language
- English
- Record Identifier
- 99450886102621
- Output Type
- Abstract
Metrics
212 Record Views